Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study (Q39362494)

11 September 2017

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study (English)

1 reference

11 September 2017

0 references

1 reference

Sunil Dogra

1

1 reference

11 September 2017

Said Beydoun

2

1 reference

11 September 2017

Jennifer Mazzola

3

1 reference

11 September 2017

Margaret Hopwood

4

1 reference

11 September 2017

Ying Wan

5

1 reference

11 September 2017

18 December 2004

1 reference

11 September 2017

European Journal of Pain

1 reference

11 September 2017

9

1 reference

11 September 2017

5

1 reference

11 September 2017

543-554

1 reference

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Compliance with inhaled medications: the relationship between diary and electronic monitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Clinical trial of carbazepine (tegretol) in trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Diagnosis and Treatment of Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Clinically important changes in acute pain outcome measures: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Comparative study of electronic vs. paper VAS ratings: a randomized, crossover trial using healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Carbamazepine in the treatment of neuralgia. Use of side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Oxcarbazepine: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Patient non-compliance with paper diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Clinical significance of reported changes in pain severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Improvement in diabetes control with a monitoring system based on a hand-held, touch-screen electronic diary

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Oxcarbazepine: an update of its efficacy in the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.11.006

10.1016/J.EJPAIN.2004.11.006

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference